Agnes S. M. Yong - Concepedia

Author

Agnes S. M. Yong

Also Known As

A S M Yong, A S Yong, A Yong, A. S. M. Yong, A. S. Yong, A. Yong, A.S.M. Yong, ASM Yong, Aaron Chung Yong Leow, Agnes S Yong

142

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

The University of Adelaide South Australia Pathology South Australian Health and Medical Research Institute Royal Adelaide Hospital National Institutes of Health

About

Agnes S. M. Yong is an author at The University of Adelaide specializing in medicine, hematology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	767
2	Cell Biology	6	6	252
3	Health Sciences	3	3	249
4	Blood Transplantation	3	3	332
5	Public Health	1	1	24

Agnes S. M. Yong

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies Katayoun Rezvani, Agnes S. M. Yong, Stephan Mielke, Blood	2007	338
Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia Francesco Dazzi, Richard Szydlo, Nicholas C.P. Cross, Blood	2000	266
Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies Maya Lewinsohn, Anna Brown, Luke M. Weinel, Blood	2015	211
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease Susan Branford, Paul Wang, David T Yeung, Blood	2018	203
Bcr-Abl Expression Levels Determine the Rate of Development of Resistance to Imatinib Mesylate in Chronic Myeloid Leukemia David Barnes, Danai Palaiologou, Eleni Panousopoulou, Cancer Research	2005	196
Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia Bipin N. Savani, Stephan Mielke, Sharon Adams, Leukemia Hematological MalignancyRadiation OncologyCell TherapyTransplantationMarrow Transplantation	2007	182
CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors Amy Hughes, Jade Clarson, Carine Tang, Blood	2017	172
Graft-versus-leukemia effects associated with detectable Wilms tumor-1–specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia Katayoun Rezvani, Agnes S. M. Yong, Bipin N. Savani, Blood	2007	167
Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML Agnes S. M. Yong, Richard Szydlo, John M. Goldman, Blood	2005	139
The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia Mohamad Mohty, Agnes S. M. Yong, Richard Szydlo, Blood	2007	133

Page 1